Related Experiment Videos
Bcl-2 expression in preinvasive and invasive cervical lesions
S S Ozalp1, O T Yalcin, H M Tanir
1Osmangazi University Faculty of Medicine, Eskişehir, Turkey.
European Journal of Gynaecological Oncology
|November 21, 2002
Summary
Bcl-2 expression is linked to cervical intraepithelial neoplasia (CIN) progression. While bcl-2 positivity correlates with longer survival in invasive cervical cancer, it
Area of Science:
- Oncology
- Molecular Biology
- Gynecologic Pathology
Background:
- Cervical intraepithelial neoplasia (CIN) represents precancerous changes in the cervix.
- Invasive cervical cancer is a significant global health concern.
- The role of apoptosis-regulating proteins like bcl-2 in cervical carcinogenesis is under investigation.
Purpose of the Study:
- To investigate the association between bcl-2 expression and clinicopathological features in CIN and invasive cervical lesions.
- To evaluate the impact of bcl-2 expression on the overall survival rate of patients with cervical cancer.
Main Methods:
- Fifty cervical tissue specimens from preinvasive and invasive lesions were analyzed.
- Immunohistochemical staining was employed to assess bcl-2 protein expression levels.
- Statistical analysis, including Cox regression, was used to correlate bcl-2 expression with survival and clinicopathological data.
Main Results:
- Bcl-2 positivity was observed in 68% of CIN lesions and 54% of invasive cervical cancers.
- A significant correlation was found between bcl-2 expression and lesion grade in CIN (p < 0.05).
- Patients with bcl-2 positive invasive cervical cancer showed a trend towards longer survival, though multivariate analysis identified histopathology and tumor stage as significant prognostic factors.
Conclusions:
- Bcl-2 expression may serve as a marker for disease progression in preinvasive cervical lesions.
- In invasive cervical carcinomas, bcl-2 expression did not emerge as an independent predictor of overall survival.
- Further research is warranted to elucidate the precise role of bcl-2 in cervical cancer pathogenesis and prognosis.